Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The changes consist of adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:33:45.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; the update appears to be a platform/UI change with no changes to the study records or history data.
    Difference
    0.1%
    Check dated 2025-11-24T16:58:42.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice from the page.
    Difference
    0.5%
    Check dated 2025-11-17T15:03:41.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new history entry dated 2025-01-27 was added to the Record History. No substantive changes to the study record content, statuses, or data were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:34:13.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Major update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T12:52:01.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Update: revision tag changed from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:28:20.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.